Data taken from [20]. Assist the determination of an appropriate course of management for patients with acute or chronic coronary thrombotic ischemic syndromes. Provide reliable and universal ...
GRCE READ THE FULL GRCE RESEARCH REPORT Grace Therapeutics, Inc (NASDAQ:GRCE) held a key opinion leader (KOL) event on November 20 th , 2024 featuring Abhishek Ray, MD of University Hospitals and ...
Researchers suggest an application to FDA may be made within the next 12 months, requesting approval to carry out a human clinical trial with the gene therapy.
The patent filing expands upon data obtained from animal model testing and the istaroxime human clinical trials in acute heart failure (AHF) and early cardiogenic shock (ECS), including the latest ...